Family Management Corp acquired a new stake in Imperva Inc (NASDAQ:IMPV) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 35,000 shares of the software maker’s stock, valued at approximately $1,689,000. Family Management Corp owned approximately 0.10% of Imperva as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in IMPV. SG Americas Securities LLC bought a new stake in Imperva during the 1st quarter worth approximately $461,000. American Century Companies Inc. increased its holdings in Imperva by 2.2% during the 1st quarter. American Century Companies Inc. now owns 172,352 shares of the software maker’s stock worth $7,463,000 after acquiring an additional 3,650 shares during the period. Prudential Financial Inc. bought a new stake in Imperva during the 1st quarter worth approximately $2,156,000. Swiss National Bank increased its holdings in Imperva by 3.9% during the 1st quarter. Swiss National Bank now owns 50,139 shares of the software maker’s stock worth $2,171,000 after acquiring an additional 1,900 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its holdings in Imperva by 3.6% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 161,722 shares of the software maker’s stock worth $7,003,000 after acquiring an additional 5,665 shares during the period. Institutional investors own 99.99% of the company’s stock.
Shares of NASDAQ:IMPV traded down $0.50 during trading on Friday, reaching $43.88. The company had a trading volume of 259,736 shares, compared to its average volume of 344,780. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of -156.71 and a beta of 1.72. Imperva Inc has a 12 month low of $37.17 and a 12 month high of $57.65.
Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Thursday, July 26th. The software maker reported ($0.26) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.33) by $0.07. Imperva had a negative net margin of 8.59% and a negative return on equity of 6.92%. The firm had revenue of $84.80 million for the quarter, compared to analyst estimates of $87.22 million. During the same quarter in the prior year, the firm earned $0.24 EPS. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. As a group, research analysts forecast that Imperva Inc will post -1.15 earnings per share for the current fiscal year.
IMPV has been the topic of a number of analyst reports. Stifel Nicolaus decreased their target price on shares of Imperva from $50.00 to $48.00 and set a “buy” rating on the stock in a report on Friday, July 27th. Evercore ISI reaffirmed a “buy” rating and set a $56.00 target price on shares of Imperva in a report on Friday, July 27th. Royal Bank of Canada reaffirmed a “buy” rating and set a $62.00 target price on shares of Imperva in a report on Friday, July 27th. BidaskClub lowered shares of Imperva from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 23rd. Finally, Zacks Investment Research raised shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, August 14th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the company. Imperva presently has a consensus rating of “Hold” and an average price target of $54.00.
Imperva Company Profile
Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.
Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.